E Fund Management Co., Ltd. Global Blood Therapeutics, Inc. Transaction History

E Fund Management Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $399,135 - $839,909	-12,319 Reduced 63.67%	7,030 $479,000
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $216,376 - $362,795	9,703 Added 100.59%	19,349 $618,000
Q1 2022 May 12, 2022	BUY	$25.68 - $35.59 $166,842 - $231,228	6,497 Added 206.32%	9,646 $334,000
Q1 2021 May 12, 2021	BUY	$38.94 - $50.85 $122,622 - $160,126	3,149 New	3,149 $128,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.